SAN FRANCISCO, CA / ACCESS Newswire / August 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”), under its Jaguar Animal Health tradename for the veterinary market, today announced it is ...
Hosted on MSN
Jaguar Animal Health Secures $10.8M Note Agreement
An update from Jaguar Animal Health ( (JAGX)) is now available. On November 12, 2025, Jaguar Health, Inc. entered into a note purchase agreement with Streeterville Capital, LLC, issuing a secured ...
Jaguar Animal Health Inc. ((JAGX)) has held its Q2 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced ...
Jaguar Animal Health ( (JAGX)) has issued an update. On January 6, 2026, Jaguar Health, Inc. entered into securities purchase agreements with two accredited investors and closed a financing in which ...
Conference attendees are invited to visit Jaguar Animal Health's exhibit booth to take part in a Take C.H.A.R.G.E. Spin the Wheel promotion for a chance to win an original painting made with the latex ...
San Francisco, CA (February 10, 2015): Jaguar Animal Health, Inc. ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal and other proprietary ...
SAN FRANCISCO--(BUSINESS WIRE)--Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"), an animal health company focused on developing and commercializing first-in-class gastrointestinal ...
“Specifically, our objective is to partner with an animal health company to achieve three parallel goals for Canalevia: Expand the U.S. indication from CID in dogs to treatment of general diarrhea in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results